AZYRADA Trademark

Trademark Overview


On Thursday, May 27, 2021, a trademark application was filed for AZYRADA with the United States Patent and Trademark Office. The USPTO has given the AZYRADA trademark a serial number of 90739249. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 4, 2023. This trademark is owned by Pfizer Inc.. The AZYRADA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatory preparations; Pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
azyrada

General Information


Serial Number90739249
Word MarkAZYRADA
Filing DateThursday, May 27, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements


Goods and ServicesAnti-inflammatory preparations; Pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 4, 2023SOU EXTENSION 3 FILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU EXTENSION 2 GRANTED
Thursday, April 13, 2023SOU EXTENSION 2 FILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 1 GRANTED
Monday, October 17, 2022SOU EXTENSION 1 FILED
Monday, October 17, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, February 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, August 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 31, 2021NEW APPLICATION ENTERED